Burning Rock Biotech (BNR) Asset Utilization Ratio (2020 - 2025)

Burning Rock Biotech's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.66 for Q4 2025.

• In Q4 2025, Asset Utilization Ratio rose 21.1% year-over-year to 0.66; the TTM figure through Dec 2025 stood at 0.66 (up 21.1% YoY), while the FY2025 annual figure was 0.65, up 22.53% from the prior year.
• Asset Utilization Ratio was 0.66 for Q4 2025 at Burning Rock Biotech, up from 0.65 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.66 in Q4 2025 to a low of 0.17 in Q1 2021.
• Historically, Asset Utilization Ratio has averaged 0.42 across 5 years, with a median of 0.44 in 2023.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio surged 67.07% in 2022, then increased 9.63% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.21 in 2021, then surged by 66.09% to 0.36 in 2022, then surged by 38.93% to 0.5 in 2023, then climbed by 9.63% to 0.54 in 2024, then rose by 21.1% to 0.66 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.66 (Q4 2025), 0.65 (Q3 2025), and 0.64 (Q2 2025), per Business Quant data.